XML 36 R25.htm IDEA: XBRL DOCUMENT

Stockholders' Equity (Tables)

9 Months Ended

Mar. 31, 2018

Stockholders' Equity

Schedule of stock-based compensation expense in the condensed consolidated statements of operations

We recorded stock-based compensation expense in the condensed consolidated statements of operations as follows (in thousands):

		Three Months Ended March 31,						Nine Months Ended March 31,
		2017			2018			2017			2018
Cost of goods sold		$	417		$	251		$	1,116		$	739
Selling, general and administrative		5,627			5,614			15,909			16,574
Research and development		159			149			335			441
Restructuring		—			—			2,902			—

Stock-based compensation expense before taxes		$	6,203		$	6,014		$	20,262		$	17,754
Less: related income tax benefit		(2,378		)	(1,864		)	(7,828		)	(5,492		)

Stock-based compensation expense, net of estimated taxes		$	3,825		$	4,150		$	12,434		$	12,262

Summary of stock option activity

		Number of Options		Weighted Average Exercise Price			Weighted- Average Remaining Contractual Term		Aggregate Intrinsic Value (in thousands)
Outstanding at June 30, 2017		780,671		$	30.00
Granted		25,379		$	85.83
Exercised		(113,255	)	$	22.73
Expired or forfeited		(5,730	)	$	73.38

Outstanding at March 31, 2018		687,065		$	32.89		3.2 years		$	23,193

Exercisable at March 31, 2018		642,629		$	29.63		2.8 years		$	23,190

Summary of RSU award activity

		Shares		Weighted- Average Fair Value
Nonvested at June 30, 2017		611,687		$	65.85
Granted		349,538		74.11
Vested		(401,773	)	65.27
Forfeited		(13,919	)	70.11

Nonvested at March 31, 2018		545,533		$	71.46